|
시장보고서
상품코드
2055094
대동맥류 시장 : 발생 부위별, 치료법별, 제품 유형별, 진단 방법별, 연령층별, 성별, 최종사용자별, 유통 채널별, 지역별Aortic Aneurysm Market, By Aneurysm Location, By Treatment Type, By Product Type, By Diagnosis Type, By Age Group, By Gender, By End User, By Distribution Channel, By Geography |
||||||
대동맥류 시장은 2026년에 55억 7,000만 달러로 추정되며, 2033년까지 128억 6,000만 달러에 이를 것으로 예상되고 있습니다. 또한 2026-2033년 CAGR 12.7%를 기록할 전망입니다.
| 보고서 범위 | 보고서 상세 | ||
|---|---|---|---|
| 기준 연도 : | 2025년 | 2026년 시장 규모 : | 55억 7,000만 달러 |
| 과거 데이터 기간 : | 2020-2024년 | 예측 기간 : | 2026-2033년 |
| 예측 기간(2026-2033년) CAGR : | 12.70% | 2033년 시장 규모 예측 : | 128억 6,000만 달러 |
세계 대동맥류 시장은 심혈관 의료기기 업계에서 매우 중요한 부분을 차지하고 있으며, 전 세계 수백만 명의 생명을 위협하는 가장 위험한 혈관 질환 중 하나를 치료하는 분야입니다.
대동맥류는 체내에서 가장 큰 동맥인 대동맥의 벽이 약해져 바깥쪽으로 부풀어 오르는 것으로 발생하며, 치료를 소홀히 할 경우 생명을 위협하는 상태를 초래할 수 있습니다. 이 시장에는 이러한 위험한 동맥 확장을 감지, 모니터링 및 치료하기 위해 설계된 진단 도구, 수술용 기기, 혈관 내 스텐트 그래프트 및 최소 침습 치료 솔루션이 폭넓게 포함되어 있습니다. 세계적인 고령화 추세에 따라 심혈관 질환, 고혈압, 동맥경화의 유병률이 증가하고 있어, 첨단 대동맥류 관리 솔루션에 대한 수요는 계속해서 높아지고 있습니다.
이 시장은 흉부 대동맥류(TAA)나 복부 대동맥류(AAA) 등 다양한 해부학적 부위에 걸쳐 있으며, 각 부위에 특화된 치료 접근법과 의료기기 기술이 요구되고 있습니다.
혈관내 동맥류 수복술(EVAR) 기술, 개창형 및 분지형 스텐트그래프트, 그리고 하이브리드 수술 기법의 혁신은 시술 위험을 줄이는 동시에 환자의 예후에 획기적인 변화를 가져왔습니다. 전 세계 의료 시스템은 대동맥류 질환으로 인한 부담이 증가함에 따라 선별 검사 프로그램, 첨단 영상 진단 기술 및 전문 치료 센터에 대한 투자를 확대하고 있으며, 이는 시장의 눈부신 성장과 기술 발전을 이끌고 있습니다.
시장 역학
세계 대동맥류 시장의 성장은 주로 몇 가지 강력한 요인에 의해 주도되고 있으며, 이러한 요인들이 결합되어 견실한 성장세를 뒷받침하고 있습니다. 세계적인 고령화가 가장 중요한 촉진요인으로 작용하고 있습니다. 이는 노화에 따른 동맥벽의 퇴행성 변화와 축적된 심혈관 위험 인자로 인해 대동맥류의 발생률이 직접적으로 높아지기 때문입니다. 고혈압, 당뇨병, 흡연 및 동맥경화성 질환의 유병률 증가가 시장 수요를 더욱 확대시키고 있는 반면, 개창형 스텐트그래프트나 복잡한 분지용 기기 등 혈관 내 치료 기술의 발전은 치료 접근성을 높이고 환자의 예후를 개선하고 있습니다.
의료 종사자와 환자들 사이에서 선별 검사 프로토콜에 대한 인식이 높아지고 있는 데다, CT 혈관조영술이나 초음파 기술 등 영상 진단 능력의 향상으로 인해 조기 발견 및 조기 개입의 비율이 증가하고 있습니다.
그러나 시장에는 뚜렷한 제약도 존재합니다. 첨단 혈관 내 기기 및 외과적 시술의 높은 비용은 개발도상국에서의 접근성을 제한하고, 의료 보험 제도상 보상 문제를 야기하고 있습니다. 혁신적인 의료기기에 대한 복잡한 규제 승인 절차는 시장 진입을 지연시키고 제조업체의 개발 비용을 증가시킬 수 있습니다. 또한, 엔드리크, 기기 이동, 장기적인 내구성에 대한 우려 등 혈관 내 시술에 수반되는 잠재적 합병증은 보수적인 의료진의 도입률을 제한할 우려가 있습니다.
이러한 과제들이 존재하지만, 신흥 시장의 의료 인프라 확충, 심혈관 질환 예방을 위한 정부 주도의 노력 확대, 그리고 의료 관광 분야의 성장을 통해 큰 기회가 창출되고 있습니다. 생분해성 스텐트 기술의 개발, 인공지능(AI)을 활용한 수술 계획, 그리고 유전자 프로파일링에 기반한 맞춤형 치료 접근법은 시장 확대와 혁신을 향한 유망한 길을 제시하고 있습니다.
본 조사의 주요 특징
- 본 조사에서는 각 부문의 잠재적 수익 기회를 파악하고, 이 시장에서 매력적인 투자 제안 매트릭스에 대해 설명하고 있습니다.
- 또한, 본 조사에서는 시장 성장 촉진요인, 시장 성장 억제요인, 기회, 신제품 출시 및 승인, 시장 동향, 지역별 전망, 그리고 주요 기업들이 채택하는 경쟁 전략에 관한 중요한 인사이트를 제공합니다.
- 본 조사에서는 다음 매개변수를 바탕으로 전 세계 복부 대동맥류 시장의 주요 기업 프로파일을 작성했습니다. 기업 개요, 제품 포트폴리오, 주요 성과, 재무 실적 및 전략.
- 본 보고서의 인사이트를 활용함으로써, 기업의 마케팅 담당자와 경영진은 향후 제품 출시, 제품 업그레이드, 시장 확대 및 마케팅 전략에 관해 정보에 기반한 의사결정을 내릴 수 있게 됩니다.
- 본 세계 대동맥류 시장 보고서는 투자자, 공급업체, 제품 제조업체, 유통업체, 신규 진출기업 및 금융 애널리스트를 포함한 이 업계의 다양한 이해관계자를 대상으로 합니다.
- 이해관계자들은 전 세계 대동맥류 시장을 분석하는 데 사용되는 다양한 전략 매트릭스를 통해 의사결정을 수월하게 내릴 수 있을 것입니다.
목차
제1장 조사 목적과 전제조건
제2장 시장 전망
제3장 시장 역학, 규제 및 동향 분석
제4장 세계의 대동맥류 시장 : 동맥류 발생 부위별, 2021년-2033년
제5장 세계의 대동맥류 시장 : 치료 유형별, 2021년-2033년
제6장 세계의 대동맥류 시장 : 제품 유형별, 2021년-2033년
제7장 세계의 대동맥류 시장 : 진단 유형별, 2021년-2033년
제8장 세계의 대동맥류 시장 : 연령층별, 2021년-2033년
제9장 세계의 대동맥류 시장 : 성별, 2021년-2033년
제10장 세계의 대동맥류 시장 : 최종사용자별, 2021년-2033년
제11장 세계의 대동맥류 시장 : 유통 채널별, 2021년-2033년
제12장 세계의 대동맥류 시장 : 지역별, 2021년-2033년
제13장 경쟁 구도
제14장 애널리스트의 제안
제15장 참고 문헌 및 조사 방법
LSH 26.06.22Aortic Aneurysm Market is estimated to be valued at USD 5.57 Bn in 2026 and is expected to reach USD 12.86 Bn by 2033, growing at a compound annual growth rate (CAGR) of 12.7% from 2026 to 2033.
| Report Coverage | Report Details | ||
|---|---|---|---|
| Base Year: | 2025 | Market Size in 2026: | USD 5.57 Bn |
| Historical Data for: | 2020 To 2024 | Forecast Period: | 2026 To 2033 |
| Forecast Period 2026 to 2033 CAGR: | 12.70% | 2033 Value Projection: | USD 12.86 Bn |
The global aortic aneurysm market represents a critical segment within the cardiovascular medical device industry, addressing one of the most life-threatening vascular conditions affecting millions worldwide.
An aortic aneurysm occurs when the wall of the aorta, the body's largest artery, weakens and bulges outward, creating a potentially fatal condition if left untreated. The market encompasses a comprehensive range of diagnostic tools, surgical devices, endovascular stent grafts, and minimally invasive treatment solutions designed to detect, monitor, and repair these dangerous arterial dilations. With aging populations globally experiencing increased prevalence of cardiovascular diseases, hypertension, and atherosclerosis, the demand for advanced aortic aneurysm management solutions continues to escalate.
The market spans various anatomical locations including thoracic aortic aneurysms (TAA) and abdominal aortic aneurysms (AAA), each requiring specialized therapeutic approaches and device technologies.
Innovation in endovascular aneurysm repair (EVAR) techniques, fenestrated and branched stent grafts, and hybrid surgical procedures has revolutionized patient outcomes while reducing procedural risks. Healthcare systems worldwide are increasingly investing in screening programs, advanced imaging technologies, and specialized treatment centers to address the growing burden of aortic aneurysmal disease, driving substantial market growth and technological advancement.
Market Dynamics
The global aortic aneurysm market growth is primarily driven by several compelling factors that collectively fuel its robust growth trajectory. The aging global population represents the most significant driver, as advanced age correlates directly with increased aortic aneurysm incidence due to arterial wall degeneration and accumulated cardiovascular risk factors. Rising prevalence of hypertension, diabetes, smoking, and atherosclerotic diseases further amplifies market demand, while technological breakthroughs in endovascular repair techniques, including fenestrated stent grafts and complex branched devices, enhance treatment accessibility and patient outcomes.
Growing awareness among healthcare professionals and patients about screening protocols, coupled with improved diagnostic imaging capabilities such as CT angiography and ultrasound technologies, drives early detection and intervention rates.
However, the market faces notable restraints including the high cost of advanced endovascular devices and surgical procedures, which limit accessibility in developing regions and create reimbursement challenges for healthcare systems. Complex regulatory approval processes for innovative medical devices can delay market entry and increase development costs for manufacturers. Additionally, potential complications associated with endovascular procedures, including endoleaks, device migration, and long-term durability concerns, may restrict adoption rates among conservative practitioners.
Despite these challenges, significant opportunities emerge through expanding healthcare infrastructure in emerging markets, increasing government initiatives for cardiovascular disease prevention, and growing medical tourism sectors. The development of biodegradable stent technologies, artificial intelligence-guided surgical planning, and personalized treatment approaches based on genetic profiling present lucrative avenues for market expansion and innovation.
Key Features of the Study
- It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
- It profiles key players in the global aortic aneurysm market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
- Key companies covered as a part of this study include Medtronic plc, Cook Medical LLC, W. L. Gore and Associates Inc., Terumo Corporation, Endologix LLC, Cardinal Health Inc., Becton Dickinson and Company (BD), Abbott Laboratories, Boston Scientific Corporation, Braun Melsungen AG, JOTEC GmbH (CryoLife / Artivion), Lombard Medical Technologies, Cordis (a Cardinal Health company / Cordis Inc.), Merit Medical Systems Inc., and LeMaitre Vascular Inc.
- Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
- The global aortic aneurysm market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
- Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global aortic aneurysm market
Market Segmentation
- Aneurysm Location Insights (Revenue, USD Bn, 2021 - 2033)
- Abdominal Aortic Aneurysm
- Thoracic Aortic Aneurysm
- Thoracoabdominal Aortic Aneurysm
- Treatment Type Insights (Revenue, USD Bn, 2021 - 2033)
- Open Surgical Repair
- Endovascular Aneurysm Repair
- Product Type Insights (Revenue, USD Bn, 2021 - 2033)
- Stent Grafts
- Catheters
- Guidewires
- Balloon Angioplasty Devices
- Other Endovascular Accessories
- Diagnosis Type Insights (Revenue, USD Bn, 2021 - 2033)
- Ultrasound (Screening & Surveillance)
- Computed Tomography Angiography (CTA)
- Magnetic Resonance Angiography (MRA)
- Conventional Catheter Angiography
- Intravascular Ultrasound (IVUS)/Intraoperative Imaging
- Age Group Insights (Revenue, USD Bn, 2021 - 2033)
- Below 60 Years
- 60-75 Years
- Above 75 Years
- Gender Insights (Revenue, USD Bn, 2021 - 2033)
- Male
- Female
- End User Insights (Revenue, USD Bn, 2021 - 2033)
- Hospitals
- Specialty Cardiac and Vascular Centers
- Ambulatory Surgical Centers
- Diagnostic Imaging Centers
- Research and Academic Institutes
- Distribution Channel Insights (Revenue, USD Bn, 2021 - 2033)
- Online
- Offline
- Regional Insights (Revenue, USD Bn, 2021 - 2033)
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- South Africa
- North Africa
- Central Africa
- Key Players Insights
- Medtronic plc
- Cook Medical LLC
- L. Gore and Associates Inc.
- Terumo Corporation
- Endologix LLC
- Cardinal Health Inc.
- Becton Dickinson and Company (BD)
- Abbott Laboratories
- Boston Scientific Corporation
- Braun Melsungen AG
- JOTEC GmbH (CryoLife / Artivion)
- Lombard Medical Technologies
- Cordis (a Cardinal Health company / Cordis Inc.)
- Merit Medical Systems Inc.
- LeMaitre Vascular Inc.
Table of Contents
1. Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
2. Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Global Aortic Aneurysm Market, By Aneurysm Location
- Global Aortic Aneurysm Market, By Treatment Type
- Global Aortic Aneurysm Market, By Product Type
- Global Aortic Aneurysm Market, By Diagnosis Type
- Global Aortic Aneurysm Market, By Age Group
- Global Aortic Aneurysm Market, By Gender
- Global Aortic Aneurysm Market, By End User
- Global Aortic Aneurysm Market, By Distribution Channel
- Global Aortic Aneurysm Market, By Region
3. Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Driver
- Restraint
- Opportunity
- Impact Analysis
- Key Developments
- Regulatory Scenario
- Product Launches/Approvals
- PEST Analysis
- PORTER's Analysis
- Merger and Acquisition Scenario
- Industry Trends
4. Global Aortic Aneurysm Market, By Aneurysm Location, 2021 - 2033, (USD Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Abdominal Aortic Aneurysm
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Thoracic Aortic Aneurysm
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Thoracoabdominal Aortic Aneurysm
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
5. Global Aortic Aneurysm Market, By Treatment Type, 2021 - 2033, (USD Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Open Surgical Repair
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Endovascular Aneurysm Repair
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
6. Global Aortic Aneurysm Market, By Product Type, 2021 - 2033, (USD Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Stent Grafts
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Catheters
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Guidewires
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Balloon Angioplasty Devices
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Other Endovascular Accessories
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
7. Global Aortic Aneurysm Market, By Diagnosis Type, 2021 - 2033, (USD Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Ultrasound (Screening & Surveillance)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Computed Tomography Angiography (CTA)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Magnetic Resonance Angiography (MRA)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Conventional Catheter Angiography
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Intravascular Ultrasound (IVUS)/Intraoperative Imaging
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
8. Global Aortic Aneurysm Market, By Age Group, 2021 - 2033, (USD Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Below 60 Years
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- 60-75 Years
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Above 75 Years
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
9. Global Aortic Aneurysm Market, By Gender, 2021 - 2033, (USD Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Male
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Female
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
10. Global Aortic Aneurysm Market, By End User, 2021 - 2033, (USD Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Hospitals
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Specialty Cardiac and Vascular Centers
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Ambulatory Surgical Centers
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Diagnostic Imaging Centers
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Research and Academic Institutes
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
11. Global Aortic Aneurysm Market, By Distribution Channel, 2021 - 2033, (USD Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Online
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Offline
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
12. Global Aortic Aneurysm Market, By Region, 2021 - 2033, Value (USD Bn)
- Introduction
- Market Share (%) Analysis, 2026, 2028 & 2033, Value (USD Bn)
- Market Y-o-Y Growth Analysis (%), 2022 - 2033, Value (USD Bn)
- Regional Trends
- North America
- Introduction
- Market Size and Forecast, By Aneurysm Location, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Treatment Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Product Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Diagnosis Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Age Group, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Gender, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Distribution Channel, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
- U.S.
- Canada
- Latin America
- Introduction
- Market Size and Forecast, By Aneurysm Location, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Treatment Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Product Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Diagnosis Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Age Group, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Gender, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Distribution Channel, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Introduction
- Market Size and Forecast, By Aneurysm Location, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Treatment Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Product Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Diagnosis Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Age Group, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Gender, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Distribution Channel, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- Introduction
- Market Size and Forecast, By Aneurysm Location, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Treatment Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Product Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Diagnosis Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Age Group, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Gender, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Distribution Channel, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- Introduction
- Market Size and Forecast, By Aneurysm Location, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Treatment Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Product Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Diagnosis Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Age Group, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Gender, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Distribution Channel, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- Introduction
- Market Size and Forecast, By Aneurysm Location, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Treatment Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Product Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Diagnosis Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Age Group, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Gender, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Distribution Channel, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Country/Region, 2021 - 2033, Value (USD Bn)
- South Africa
- North Africa
- Central Africa
13. Competitive Landscape
- Medtronic plc
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Cook Medical LLC
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- L. Gore and Associates Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Terumo Corporation
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Endologix LLC
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Cardinal Health Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Becton Dickinson and Company (BD)
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Abbott Laboratories
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Boston Scientific Corporation
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Braun Melsungen AG
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- JOTEC GmbH (CryoLife / Artivion)
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Lombard Medical Technologies
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Cordis (a Cardinal Health company / Cordis Inc.)
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Merit Medical Systems Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- LeMaitre Vascular Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
14. Analyst Recommendations
- Wheel of Fortune
- Analyst View
- Coherent Opportunity Map
15. References and Research Methodology
- References
- Research Methodology
- About us
